HARAYA; Kenta

Patent Applications and Registrations

Patent applications and USPTO patent grants for HARAYA; Kenta.The latest application filed is for "methods of neutralizing il-8 biological activity".

Company Profile

9.5.16

HARAYA; Kenta - Shizuoka JP
Haraya; Kenta - Singapore SG

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Neutralizing Il-8 Biological Activity App 20220089715 - IGAWA; Tomoyuki ; et al.	2022-03-24
Cxcr3 Ligand App 20220017585 - YAMAMOTO; Yohei ; et al.	2022-01-20
Methods of neutralizing IL-8 biological activity Grant 11,180,548 - Igawa , et al. November 23, 2	2021-11-23
Anti-complement Component Antibodies And Methods Of Use App 20210198347 - FUKUZAWA; Taku ; et al.	2021-07-01
Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-related Disease And A Method For Treating Or Preventing A C5-related Disease App 20200407432 - SHINOMIYA; Kenji ; et al.	2020-12-31
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20200199241 - Igawa; Tomoyuki ; et al.	2020-06-25
Antibodies Comprising An Antigen-binding Domain Whose Antigen-binding Activity Changes According To The Ion Concentration Condit App 20200172610 - IGAWA; Tomoyuki ; et al.	2020-06-04
Antigen-binding Molecule Inducing Immune Response To Target Antigen App 20200115447 - Igawa; Tomoyuki ; et al.	2020-04-16
Method for altering plasma retention and immunogenicity of antigen-binding molecule Grant 10,618,965 - Igawa , et al.	2020-04-14
Antigen-binding molecule inducing immune response to target antigen Grant 10,556,949 - Igawa , et al. Feb	2020-02-11
Nucleic acids encoding IL-8 antibodies Grant 10,519,229 - Igawa , et al. Dec	2019-12-31
Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-related Disease And A Method For Treating Or Preventin App 20190367599 - SHINOMIYA; Kenji ; et al.	2019-12-05
Antigen-binding Molecule For Promoting Elimination Of Antigens App 20190112393 - Igawa; Tomoyuki ; et al.	2019-04-18
ANTIBODIES COMPRISING AN ANTIGEN-BINDING DOMAIN WHOSE ANTIGEN-BINDING ACTIVITY CHANGES ACCORDING TO THE ION CONCENTRATION CONDITION, Fc REGION VARIANTS, OR IL-8-BINDING ANTIBODIES App 20180258163 - IGAWA; Tomoyuki ; et al.	2018-09-13
Antibodies Comprising an Ion Concentration Dependent Antigen-Binding Domain, Fc Region Variants, IL-8-Binding Antibodies, and Uses Thereof App 20160229908 - IGAWA; Tomoyuki ; et al.	2016-08-11
Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIB App 20160046693 - Igawa; Tomoyuki ; et al.	2016-02-18
Antigen-binding Molecule For Promoting Elimination Of Antigens App 20140335089 - Igawa; Tomoyuki ; et al.	2014-11-13
Antigen-binding Molecule Inducing Immune Response To Target Antigen App 20140255398 - Igawa; Tomoyuki ; et al.	2014-09-11
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20140105889 - Igawa; Tomoyuki ; et al.	2014-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.